Medlab Partners Forum
From the latest challenges in the medical laboratory industry to revolutionary innovations, the Medlab Partners Forum presents a unique opportunity to empower yourself with both theoretical knowledge and practical insights. In association with industry leaders RCPath and Frost & Sullivan, join us for a chance to expand your knowledge base and network with field experts.
5th February
Brought to you by:
Frost & Sullivan Think Tank Session:
Strategic Investments and Growth Opportunities: Reshaping the Future of Laboratories and Diagnostics Industry in the Middle East
Monday 5th February I 11:00 - 12:00
Lagos room I Z1.C01
In the dynamic landscape of the Middle East’s laboratories and diagnostics industry, strategic investments and growth opportunities are playing a pivotal role in shaping its future trajectory. The region's increased focus on healthcare and advancements in medical technologies are driving demand for cutting-edge diagnostic solutions, including at-home testing and early cancer detection, treatment, and care.
Investments in research, partnerships, and technology adoption are set to drive transformative growth. Integration of innovative tools like molecular diagnostics and artificial intelligence (AI)-driven analysis promises enhanced patient and clinician experiences, ensuring accuracy and efficiency in care.
Collaborative efforts between public and private sectors are positioning the Middle East as a hub for medical innovation with a focus on digital solutions, contributing to economic growth and improved healthcare outcomes.
Our distinguished panel of healthcare leaders will share their expertise and will address pressing questions like:
- What are the key drivers and challenges for the laboratories and diagnostics industry in the Middle East over the next 5-10 years?
- What current trends are driving growth in the laboratories and diagnostics industry in the Middle East?
- How is the regulatory environment in the Middle East influencing the laboratories and diagnostics industry?
- How important is collaboration and partnerships for companies looking to expand their presence in the Middle East?
- Which opportunities and technologies are likely to drive significant growth in the foreseeable future?
- What factors should investors consider when developing investment strategies for the laboratories and diagnostics industry in the Middle East?
Moderator: Aroop Zutshi, Global President & Managing Partner, Frost & Sullivan
Panelists:
- Ahmed Mahran, Head, Business Management Laboratory Solutions, Middle East & Africa, Siemens
- Dr Scott McKeown, Product Manager, Randox
- Unmesh Lal, Research Director - Healthcare and Lifesciences Practice & Growth Coach, Frost & Sullivan, Germany
- Virasath A Khan, Director - Strategic Business Development, Thermo Fisher Scientific, Dubai, UAE
- Dr Ziad Peerwani, Medical Director, Cleveland Clinic Laboratories, Pathology & Laboratory Medicine Institute-PLMI, Cleveland, Ohio, USA
Brought to you by:
The Global Challenge of Antimicrobial Resistance: In the Middle East and Beyond
Monday 5th February I 13:45 - 15:45
Lagos room I Z1.C01
Join The Royal College of Pathologists to learn about their international work, the global challenge of antimicrobial resistance and have the opportunity to network with the President, College Fellows and members of their international team.
On Monday 5 February between 13:45 – 15:45, we invite you to the Royal College of Pathologists for an afternoon of learning, networking and afternoon tea in the company of Dr Bernie Croal, on his first overseas engagement since becoming President. He will also be joined by Fellows of the College, and members of the International Team.
Dr Croal will open the workshop by sharing some of the College’s history and his vision for the College and its international work. Then Professor Walid Al-Wali will deliver a presentation on the ‘The Global Challenge of Antimicrobial Resistance: In the Middle East and Beyond.’
RCPath Speakers:
- Dr Bernie Croal, President, The Royal College of Pathologists
- Prof Walid Al-Wali, Consultant Medical Microbiologist, Vice-Chair of Clinical Pathology, The Hamad Medical Corporation, Doha, Qatar
